Patricia Formento - Concepedia

Author

Patricia Formento

Centre Antoine Lacassagne

Also Known As

P FORMENTO, P Formento, P. Formento, Patricia Formento

100

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Centre Antoine Lacassagne Centre Hospitalier Universitaire de Nice Centre Hospitalier Universitaire de Clermont-Ferrand Institut Paoli-Calmettes Inserm

About

Patricia Formento is an author at Centre Antoine Lacassagne specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	1.4K
2	Biochemistry	9	9	297
3	Natural Sciences	6	6	198
4	Engineering	1	1	82
5	Biology	1	1	82

Patricia Formento

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. M C Etienne, S. Chéradame, Jean–Louis Fischel, Journal of Clinical Oncology	1995	284
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment J Gioanni, Jean–Louis Fischel, Jean-Claude Lambert, European Journal of Cancer and Clinical Oncology Tumor InnervationMedicinePathologyOncologyCell Biology	1988	200
Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses Marie‐Christine Etienne, M Chazal, Pierre Laurent‐Puig, Journal of Clinical Oncology	2002	176
Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’) Nicolas Magné, Jean–Louis Fischel, A Dubreuil, British Journal of Cancer	2002	156
K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy Marie-Christine Étienne-Grimaldi, Jean–Louis Formento, M Francoual, Clinical Cancer Research	2008	151
Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients Marie‐Christine Etienne, Jean–Louis Formento, M Chazal, Pharmacogenetics Optimal Fluoropyrimidine EfficacyFluorouracil-based TreatmentOncogenic AgentMedicineGenetics	2004	132
Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity S. Beauclair, Patricia Formento, Jean–Louis Fischel, Annals of Oncology Trastuzumab-related CardiotoxicityPathologyImmune-related Gene PolymorphismBreast CancerCancer Genetics	2007	118
Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer Nicolas Magné, Jean–Louis Fischel, A Dubreuil, British Journal of Cancer	2002	112
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity M-C Etienne, Karine Ilc, J. L. Formento, British Journal of Cancer	2004	105
Cell growth inhibitory effects of caulerpenyne, a sesquiterpenoid from the marine algae Caulerpa taxifolia. J-L Fischel, Rodolphe Lemée, Patricia Formento, PubMed EngineeringChemoprevention StrategyPathologyCulture MediumTumor Biology	1996	82

Page 1